Form 8-K

8-K — Simulations Plus, Inc.

Accession: 0001023459-26-000037

Filed: 2026-07-09

Period: 2026-07-09

CIK: 0001023459

SIC: 7373 (SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN)

Item: Results of Operations and Financial Condition

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — slp-20260709.htm (Primary)

EX-99.1 (slp-2026531xexx991x263.htm)

EX-99.2 (slpearningscalldeck263.htm)

GRAPHIC (slp-20260709_g1.gif)

GRAPHIC (slp_toplogo.gif)

GRAPHIC (slpearningscalldeck263001.jpg)

GRAPHIC (slpearningscalldeck263002.jpg)

GRAPHIC (slpearningscalldeck263003.jpg)

GRAPHIC (slpearningscalldeck263004.jpg)

GRAPHIC (slpearningscalldeck263005.jpg)

GRAPHIC (slpearningscalldeck263006.jpg)

GRAPHIC (slpearningscalldeck263007.jpg)

GRAPHIC (slpearningscalldeck263008.jpg)

GRAPHIC (slpearningscalldeck263009.jpg)

GRAPHIC (slpearningscalldeck263010.jpg)

GRAPHIC (slpearningscalldeck263011.jpg)

GRAPHIC (slpearningscalldeck263012.jpg)

GRAPHIC (slpearningscalldeck263013.jpg)

GRAPHIC (slpearningscalldeck263014.jpg)

GRAPHIC (slpearningscalldeck263015.jpg)

GRAPHIC (slpearningscalldeck263016.jpg)

GRAPHIC (slpearningscalldeck263017.jpg)

GRAPHIC (slpearningscalldeck263018.jpg)

GRAPHIC (slpearningscalldeck263019.jpg)

GRAPHIC (slpearningscalldeck263020.jpg)

GRAPHIC (slpearningscalldeck263021.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: slp-20260709.htm · Sequence: 1

slp-20260709

0001023459false00010234592026-07-092026-07-09

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

July 9, 2026

(Date of the earliest event reported)

Simulations Plus, Inc.

(Exact name of registrant as specified in its charter)

California 001-32046 95-4595609

(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

600 Park Offices Drive, Suite 300 #4134, Durham, NC 27713

(Address of principal executive offices) (Zip Code)

661-723-7723

Registrant's telephone number, including area code

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered

Common Stock, par value $0.001 per share SLP The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 2.02 Results of Operations and Financial Condition

On July 9, 2026, Simulations Plus, Inc., a California corporation (the “Company”), issued a press release announcing financial results for its third quarter ended May 31, 2026. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this “Report”).

Item 7.01 Regulation FD Disclosure

On July 9, 2026, the Company made available an investor presentation containing supplemental information regarding its financial results for the fiscal quarter ended May 31, 2026. A copy of the presentation is furnished as Exhibit 99.2 to this Report.

In accordance with General Instructions B.2 of Form 8-K, the information in this Report, including Exhibit 99.1 and 99.2 (together, the “Exhibits”), is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing to this Report.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS

This Report, including the disclosures set forth herein and in the Exhibits attached hereto, contains certain forward-looking statements that involve substantial risks and uncertainties. When used herein, the terms “anticipates,” “expects,” “estimates,” “believes” and similar expressions, as they relate to us or our management, are intended to identify such forward-looking statements.

Forward-looking statements in this Report or reports hereafter furnished, including in other publicly available documents filed with the Securities and Exchange Commission (the “Commission”), to the Company’s stockholders and other publicly available statements issued or released by us involve known and unknown risks, uncertainties and other factors which could cause our actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. Such future results are based upon management’s best estimates based upon current conditions and the most recent results of operations. These risks include, but are not limited to, the risks set forth herein and in such other documents filed with the Commission, each of which could adversely affect our business and the accuracy of the forward-looking statements contained herein. Our actual results, performance or achievements may differ materially from those expressed or implied by such forward-looking statements.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

99.1

Press release issued on July 9, 2026.

99.2

PowerPoint presentation

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

SIMULATIONS PLUS, INC.

Dated: July 9, 2026

By: /s/ Will Frederick

Will Frederick

Executive Vice President and Chief Financial Officer

EX-99.1

Filename: slp-2026531xexx991x263.htm · Sequence: 2

Document

Exhibit 99.1

Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results

RESEARCH TRIANGLE PARK, NC, July 9, 2026 – Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported financial results for its third quarter fiscal 2026, ended May 31, 2026.

Third Quarter 2026 Financial Highlights (as compared to third quarter 2025)

•Total revenue increased 7% to $21.9 million

•Software revenue was flat at $12.6 million, representing 58% of total revenue

•Services revenue increased 20% to $9.3 million, representing 42% of total revenue

•Gross profit was $15.1 million and gross margin was 69%, compared to $13.0 million and 64%

•Net income of $3.6 million and diluted earnings per share of $0.18, compared to net loss of $67.3 million and diluted losses per share of $3.35

•Adjusted EBITDA of $7.9 million, representing 36% of total revenue, compared to $7.4 million, representing 37% of total revenue

•Adjusted net income of $6.1 million and adjusted diluted EPS of $0.30 compared to adjusted net income of $9.0 million and adjusted diluted EPS of $0.45

Nine Months 2026 Financial Highlights (as compared to nine months 2025)

•Total revenue increased 5% to $64.6 million

•Software revenue decreased 2% to $36.1 million, representing 56% of total revenue

•Services revenue increased 14% to $28.5 million, representing 44% of total revenue

•Gross profit was $42.2 million and gross margin was 65%, compared to $36.4 million and 59%

•Net income of $8.8 million and diluted earnings per share of $0.43, compared to net loss of $64.0 million and diluted losses per share of $3.19

•Adjusted EBITDA of $20.2 million, representing 31% of total revenue, compared to $18.5 million, representing 30% of total revenue

•Adjusted net income of $15.7 million and adjusted diluted EPS of $0.78, compared to $18.7 million and adjusted diluted EPS of $0.93

Management Commentary

“We delivered solid third quarter results, with revenue increasing 7%, highlighted by strength in our services revenue, which grew 20%, while software revenue was flat year over year,” said Shawn O'Connor, Chief Executive Officer of Simulations Plus. “Our performance reflects the resilience of our business model and the value our solutions provide to clients across the drug development lifecycle.”

“Subsequent to quarter end, on June 15, 2026, we entered into a definitive merger agreement to be acquired by affiliates of Altaris, LLC (“Altaris”). We believe the transaction better positions Simulations Plus to further advance its scientific leadership and expand the impact of our model-informed and AI-enabled solutions. As we move toward the expected closing in the fourth quarter of calendar 2026, we remain focused on delivering for our clients and executing at a high level throughout this transition.”

Non-GAAP Financial Measures

This press release contains “non-GAAP financial measures,” which are measures that either exclude or include amounts that are not excluded or included in the most directly comparable measures calculated and presented in accordance with U.S. generally accepted accounting principles (“GAAP”).

A further explanation and reconciliation of these non-GAAP financial measures is included below and in the financial tables in this release.

The Company believes that the non-GAAP financial measures presented facilitate an understanding of operating performance and provide a meaningful comparison of its results between periods. The Company’s management uses non-GAAP financial measures to, among other things, evaluate its ongoing operations in relation to historical results, for internal planning and forecasting purposes, and in the calculation of performance-based compensation. Adjusted EBITDA and Adjusted Diluted EPS represent measures that we believe are customarily used by investors and analysts to evaluate the financial performance of companies in addition to the GAAP measures that we present. Our management also believes that these measures are useful in evaluating our core operating results. However, Adjusted EBITDA and Adjusted Diluted EPS are not measures of financial performance under accounting principles generally accepted in the United States of America and should not be considered an alternative to net income, operating income, or diluted EPS as indicators of our operating performance or to net cash provided by operating activities as a measure of our liquidity. We believe the Company’s Adjusted EBITDA and Adjusted Diluted EPS measures provide information that is directly comparable to that provided by other peer companies in our industry, but other companies may calculate non-GAAP financial results differently, particularly related to nonrecurring, unusual items.

Please note that the Company has not reconciled the adjusted EBITDA or adjusted diluted earnings per share forward-looking guidance included in this press release to the most directly comparable GAAP measures because this cannot be done without unreasonable effort due to the variability and low visibility with respect to costs related to acquisitions, financings, and employee stock compensation programs, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.

Adjusted EBITDA

Adjusted EBITDA represents net income excluding the effect of interest expense (income), provision (benefit) for income taxes, depreciation and amortization, equity-based compensation expense, loss (gain) on currency exchange, impairment charges, change in fair value of contingent consideration, reorganization expense, acquisition and integration expense, and other items not indicative of our ongoing operating performance.

Adjusted Net Income and Adjusted Diluted EPS

Adjusted net income and adjusted diluted earnings per share exclude the effect of amortization, equity-based compensation expense, loss (gain) on currency exchange, impairment charges, change in fair value of contingent consideration, reorganization expense, acquisition and integration expense, and other items not indicative of our ongoing operating performance as well as the income tax provision adjustment for such charges.

The Company excludes the above items because they are outside of the Company’s normal operations and/or, in certain cases, are difficult to forecast accurately.

About Simulations Plus, Inc.

Simulations Plus is a global leader in model-informed and AI-accelerated drug development. We create value for our clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through innovative science-based software and consulting solutions. For more information, visit www.simulations-plus.com.

Forward-Looking Statements

Except for historical information, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties. Words like “believe,” “will”, “can”, “expect,” “anticipate,” and similar expressions (or the negative of such terms, as well as other words or expressions referencing future events, conditions, or circumstances) mean that these are our best estimates as of this writing, but there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. Forward-looking statements include but are not limited to statements regarding the effects of the definitive merger agreement, the anticipated closing date, and our fiscal year 2026 guidance. These forward-looking statements are based on current assumptions and expectations that involve risks and uncertainties that could cause the actual results to differ materially from those expressed or implied. Factors that could cause or contribute to such differences include, but are not limited to: effectiveness of our internal operational structure, our ability to maintain our competitive advantages and commercialize AI and cloud-enabled solutions, evolving regulatory and data privacy standards governing AI technologies, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, market conditions, macroeconomic factors, and a sustainable market. Further information on our risk factors is contained in our quarterly, annual, and current reports and filed with the U.S. Securities and Exchange Commission.

Investor Relations Contact:

Lisa Fortuna

Financial Profiles

310-622-8251

slp@finprofiles.com

SIMULATIONS PLUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(Unaudited)

Three Months Ended Nine Months Ended

(in thousands, except per common share and common share data) May 31, 2026 May 31, 2025 May 31, 2026 May 31, 2025

Revenues

Software $ 12,608 $ 12,615 $ 36,126 $ 36,814

Services 9,278 7,748 28,472 24,905

Total revenues 21,886 20,363 64,598 61,719

Cost of revenues

Software 1,513 2,540 4,573 7,765

Services 5,246 4,791 17,864 17,577

Total cost of revenues 6,759 7,331 22,437 25,342

Gross profit 15,127 13,032 42,161 36,377

Operating expenses

Research and development 3,406 1,216 9,856 5,207

Sales and marketing 2,538 2,680 8,647 9,248

General and administrative 4,684 6,141 12,816 16,089

Impairments — 77,221 — 77,221

Total operating expenses 10,628 87,258 31,319 107,765

Income (loss) from operations 4,499 (74,226) 10,842 (71,388)

Other income, net 307 182 820 1,122

Income (loss) before income taxes 4,806 (74,044) 11,662 (70,266)

Income tax (expense) benefit (1,231) 6,727 (2,876) 6,229

Net income (loss) $ 3,575 $ (67,317) $ 8,786 $ (64,037)

Earnings per share

Basic $ 0.18 $ (3.35) $ 0.44 $ (3.19)

Diluted $ 0.18 $ (3.35) $ 0.43 $ (3.19)

Weighted-average common shares outstanding

Basic 20,209 20,113 20,170 20,092

Diluted 20,239 20,113 20,233 20,092

Other comprehensive income (loss), net of tax

Foreign currency translation adjustments 10 41 15 (27)

Unrealized (losses) gains on available-for-sale securities (8) — (14) 4

Comprehensive income (loss) $ 3,577 $ (67,276) $ 8,787 $ (64,060)

SIMULATIONS PLUS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(in thousands, except per common share and common share data) May 31, 2026 August 31, 2025

ASSETS

Current assets

Cash and cash equivalents $ 35,324 $ 30,853

Accounts receivable, net of allowance for credit losses of $59 and $187

17,202 9,717

Prepaid income taxes 263 1,777

Prepaid expenses and other current assets 7,670 7,702

Short-term investments 14,666 1,500

Total current assets 75,125 51,549

Long-term assets

Capitalized computer software development costs, net of accumulated amortization of $24,187 and $21,863 11,203 11,117

Property and equipment, net 513 880

Operating lease right-of-use assets 395 407

Intellectual property, net of accumulated amortization of $9,822 and $9,021

5,396 6,197

Other intangible assets, net of accumulated amortization of $5,127 and $4,399

11,074 11,896

Goodwill 43,717 43,717

Deferred tax assets, net 4,168 4,774

Other assets 1,385 1,399

Total assets $ 152,976 $ 131,936

LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities

Accounts payable $ 2,234 $ 470

Accrued compensation 4,888 2,010

Accrued expenses 1,054 1,343

Operating lease liability - current portion 112 206

Deferred revenue 5,278 2,696

Total current liabilities 13,566 6,725

Long-term liabilities

Operating lease liability - net of current portion 375 410

Total liabilities 13,941 7,135

Commitments and contingencies

Shareholders' equity

Preferred stock, $0.001 par value — 10,000,000 shares authorized; no shares issued and outstanding $ — $ —

Common stock, $0.001 par value; 50,000,000 shares authorized, 20,216,438 and 20,137,480 shares issued and outstanding as of May 31, 2026, and August 31, 2025 20 20

Additional paid-in capital 164,863 159,416

Accumulated deficit (25,578) (34,364)

Accumulated other comprehensive loss (270) (271)

Total shareholders' equity 139,035 124,801

Total liabilities and shareholders' equity $ 152,976 131,936

SIMULATIONS PLUS, INC.

Reconciliation of Adjusted EBITDA to Net Income (loss) (1)

(Unaudited)

Three months ended Nine months ended

(in thousands) May 31, 2026 May 31, 2025 May 31, 2026 May 31, 2025

Net income (loss) $ 3,575 $ (67,317) $ 8,786 $ (64,037)

Excluding:

Interest income and expense, net (344) (170) (899) (483)

Provision for income taxes 1,231 (6,727) 2,876 (6,229)

Depreciation and amortization 1,368 2,318 4,261 6,857

Stock-based compensation 1,557 1,279 4,525 4,425

Loss on currency exchange 43 (35) 85 (22)

Impairments — 77,221 — 77,221

(Income) loss from disposal of fixed assets (6) 23 (6) 23

Change in value of contingent consideration — — — (640)

Reorganization expense 4 845 4 1,260

Mergers & Acquisitions expense 462 — 527 133

Adjusted EBITDA $ 7,890 $ 7,437 $ 20,159 $ 18,508

(1) Numbers may not add due to rounding

SIMULATIONS PLUS, INC.

Reconciliation of Adjusted Diluted EPS to Diluted EPS (1)

(Unaudited)

Three months ended Nine months ended

(in thousands, except Diluted EPS and Adjusted Diluted EPS)

May 31, 2026 May 31, 2025 May 31, 2026 May 31, 2025

Net income (loss) $ 3,575 $ (67,317) $ 8,786 $ (64,037)

Excluding:

Amortization 1,340 2,165 4,059 6,425

Stock-based compensation 1,557 1,279 4,525 4,425

(Gain) loss on currency exchange 43 (35) 85 (22)

Mergers & Acquisitions expense 462 — 527 133

Change in value of contingent consideration — — — (640)

Reorganization expense 4 845 4 1,260

Impairments — 77,221 — 77,221

(Income) loss from disposal of fixed assets (6) 23 (6) 23

Tax effect on above adjustments (877) (5,153) (2,267) (6,119)

Adjusted Net income $ 6,098 $ 9,028 $ 15,713 $ 18,669

Weighted-avg. common shares outstanding:

Diluted weighted-avg. common shares outstanding 20,239 20,113 20,233 20,092

Diluted EPS $ 0.18 $ (3.35) $ 0.43 $ (3.19)

Adjusted Diluted EPS $ 0.30 $ 0.45 $ 0.78 $ 0.93

(1) Numbers may not add due to rounding

EX-99.2

Filename: slpearningscalldeck263.htm · Sequence: 3

slpearningscalldeck263

Q3 - FY26 July 9, 2026 Nasdaq: SLP

Safe Harbor Statement Except for historical information, the matters discussed in this presentation are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Words like “believe,” “will”, “can”, “expect,” “anticipate” and similar expressions (or the negative of such terms, as well as other words or expressions referencing future events, conditions or circumstances) mean that these are our best estimates as of this writing, but there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. Statements include but are not limited to those relating to fiscal year 2026 guidance, expected revenue growth and mix, margins and profitability, demand for our services and software, pricing actions, client spending levels and long-term business strategies. Factors that could cause or contribute to such differences include, but are not limited to: effectiveness of our operational structure, our ability to maintain our competitive advantages and commercialize AI and cloud-enabled solutions, evolving regulatory and data privacy standards governing AI technologies, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, market conditions, macroeconomic factors, and a sustainable market. Further information on our risk factors is contained in our quarterly, annual and current reports and filed with the U.S. Securities and Exchange Commission. Non-GAAP Financial Measures This presentation includes certain financial measures not presented in accordance with generally accepted accounting principles (“GAAP”) such as Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, and Adjusted Diluted EPS and certain ratios and other metrics derived there from. These non-GAAP financial measures are not measures of financial performance in accordance with GAAP and may exclude items that are significant in understanding and assessing financial results. Therefore, these measures should not be considered in isolation or as an alternative to net income, cash flows from operations or other measures of profitability, liquidity or performance under GAAP. You should be aware that the presentation of these measures may not be comparable to similarly-titled measures used by other companies. We believe (i) these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends; and (ii) that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends in and in comparing financial measures with other similar companies, many of which present similar non- GAAP financial measures to investors. These non-GAAP financial measures are subject to inherent limitations as they reflect the exercise of judgments by management about which expense and income are excluded or included in determining these non-GAAP financial measures. Reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are set forth in the appendix to this presentation. 1

Third Quarter 2026 Highlights $0.18 Diluted EPS $21.9M Revenue 36% Adj. EBITDA Margin +7% Revenue Growth Current period Prior Year Comparison (3Q25) $0.30 Adj. Diluted EPS $20.4M Revenue $(3.35) Diluted EPS (1) 37% Adj. EBITDA Margin +10% $0.45 Revenue Growth Adj. Diluted EPS 2 (1) Diluted EPS includes a non-cash impairment charge of $77.2 million

Trailing Twelve Months (TTM) Highlights $0.40 Diluted EPS $82.1M Revenue 29% Adj. EBITDA Margin +2% Revenue Growth Current period Prior Year Comparison (3Q25) $0.88 Adj. Diluted EPS $80.4M Revenue $(3.14) Diluted EPS (1) 28% Adj. EBITDA Margin +20% Revenue Growth $1.10 (1) Diluted EPS includes a non-cash impairment charge of $77.2 million Adj. Diluted EPS 3

Software Highlights $18.7M Revenue $0.04 Diluted EPS 22% Adj. EBITDA Margin -1% Q3 Revenue Decline +2% Q3 Revenue Growth -33% Q3 Revenue Decline +3% TTM Revenue Growth +3% TTM Revenue Growth -66% TTM Revenue Decline – Overall software revenue was flat for 3Q26 and -3% for TTM – Renewal rates impacted by client consolidations and site closures Pro-ficiency® CLINICAL OPS 4

Services Highlights $18.7M Revenue $0.04 Diluted EPS 22% Adj. EBITDA Margin +19% Revenue Growth $0.18 Adj. Diluted EPS +26% Q3 Revenue Growth +2% Q3 Revenue Growth TTM Revenue Growth TTM Revenue Growth +6% +22% – Overall services revenue growth of 20% for 3Q26 and 10% for TTM – Total backlog $23.3M Med Comm Services COMMERCIALIZATION 5

Revenue - Q3 FY26 58% 42% Software Services 62% 38% Software Services (in millions) Software Revenue Growth Total Revenue Growth Services Revenue Growth +7% 0% +20% 3Q26 Mix 3Q25 Mix $11.9 $12.6 $12.6 $6.6 $7.7 $9.3 $18.5 $20.4 $21.9 Software Services 3Q24 3Q25 3Q26 6

Revenue - YTD FY26 56% 44% Software Services 60% 40% Software Services (in millions) Software Revenue Decline Total Revenue Growth Services Revenue Growth +5% -2% +14% FY26 Mix FY25 Mix $31.1 $36.8 $36.1 $20.2 $24.9 $28.5 $51.3 $61.7 $64.6 Software Services FY24 FY25 FY26 7

Revenue - Trailing Twelve Months (TTM) 55% 45% Software Services 58% 42% Software Services (in millions) Software Revenue Growth Total Revenue Growth Services Revenue Growth +2% -3% +10% 3Q26 Mix 3Q25 Mix $40.4 $46.7 $45.1 $26.5 $33.7 $36.9 $67.0 $80.4 $82.1 Software Services 3Q24 3Q25 3Q26 8

Software Solutions as % of Software Revenue 20% 78% 2% 3Q26 18% 79% 3% TTM GastroPlus® • 12 new clients • 6 upsells to existing clients ADMET Predictor® • 9 new clients • 9 upsells to existing clients MonolixSuite™ • 11 new clients • 7 upsells to existing clients Third Quarter Highlights Discovery Development Discovery Development Clinical Ops Discovery Development Clinical Ops 9

Software Performance Metrics - Q3 FY26 $97 $96 $105 3Q24 3Q25 3Q26 Avg. Revenue per Client (in thousands) Commercial Clients Renewal Rate* (fee based) 93% 84% 90% 3Q24 3Q25 3Q26 10 *Excludes perpetual licenses for all periods

Software Performance Metrics - TTM Avg. Revenue per Client (in thousands) Renewal Rate* (fee based) $131 $140 $152 3Q24 3Q25 3Q26 93% 89% 89% 3Q24 3Q25 3Q26 303 316 289 3Q24 3Q25 3Q26 Commercial Clients Clients (end of period) 11 *Excludes perpetual licenses for all periods

Services Solutions as % of Services Revenue 22% 78% Q3 FY26 24% 76% TTM Development Commercialization Development Commercialization 12

Services Performance Metrics Q3 FY26 $0.3 $0.1 $19.6 $15.4 $17.9 $5.0 $5.3$19.6 $20.7 $23.3 Discovery Development Commercialization 3Q24 3Q25 3Q26 181 145 165 56 34 181 202 199 Discovery Development Commercialization 3Q24 3Q25 3Q26 Total Projects Backlog (in millions) 13

Income Statement Summary - Q3 FY26 (1) (in millions, except Diluted EPS and Adjusted Diluted EPS) 3Q26 % of Rev 3Q25 % of Rev Revenue $21.9 100% $20.4 100% Cost of revenue 6.8 31% 7.3 36% Gross profit 15.1 69% 13.0 64% R&D 3.4 16% 1.2 6% S&M 2.5 12% 2.7 13% G&A excluding nonrecurring 4.2 19% 5.3 26% Nonrecurring 0.5 2% 78.1 383% Total operating expense 10.6 49% 87.3 429% Income (loss) from operations 4.5 21% (74.2) -365% Income (loss) before income taxes 4.8 22% (74.0) -364% Income tax (expense) benefit (1.2) -6% 6.7 33% Net income (loss) $3.6 16% $(67.3) -331% Diluted EPS $0.18 $(3.35) Adjusted EBITDA $7.9 36% $7.4 37% Adjusted Diluted EPS $0.30 $0.45 (1) Numbers may not add due to rounding 14

Income Statement Summary - YTD FY26 (1) (in millions, except Diluted EPS and Adjusted Diluted EPS) FY26 % of Rev FY25 % of Rev Revenue $64.6 100% $61.7 100% Cost of revenue 22.4 35% 25.3 41% Gross profit 42.2 65% 36.4 59% R&D 9.9 15% 5.2 8% S&M 8.6 13% 9.2 15% G&A excluding nonrecurring 12.3 19% 14.7 24% Nonrecurring 0.5 1% 78.6 127% Total operating expense 31.3 48% 107.8 175% Income (loss) from operations 10.8 17% (71.4) -116% Income (loss) before income taxes 11.7 18% (70.3) -114% Income tax (expense) benefit (2.9) -4% 6.2 10% Net income (loss) $8.8 14% $(64.0) -104% Diluted EPS $0.43 $(3.19) Adjusted EBITDA $20.2 31% $18.5 30% Adjusted Diluted EPS $0.78 $0.93 (1) Numbers may not add due to rounding 15

Balance Sheet Summary (1) (in millions) (1) Numbers may not add due to rounding May 31, 2026 August 31, 2025 Cash and short-term investments $50.0 $32.4 Other current assets 25.1 19.2 Long term assets 77.9 80.4 Total assets $153.0 $131.9 Current liabilities 13.6 6.7 Long-term liabilities 0.4 0.4 Total liabilities 13.9 7.1 Shareholders’ equity 139.0 124.8 Total liabilities and shareholders’ equity $153.0 $131.9 16

Fiscal 2026 Guidance Guidance Total Revenue $79M - $82M Total Revenue Growth 0% - 4% Software Revenue Mix 57% - 62% Adjusted EBITDA Margin (1) 26% - 30% Adjusted Diluted EPS (2) $0.75 - $0.85 (1) Adjusted EBITDA represents net income excluding the effect of interest expense (income), provision (benefit) for income taxes, depreciation and amortization, equity-based compensation expense, loss (gain) on currency exchange, impairment charges, change in fair value of contingent consideration, reorganization expense, acquisition and integration expense and other items not indicative of our ongoing operating performance. (2) Adjusted net income and adjusted diluted earnings per share exclude the effect of amortization, equity-based compensation expense, loss (gain) on currency exchange, impairment charges, change in fair value of contingent consideration, reorganization expense, acquisition and integration expense and other items not indicative of our ongoing operating performance as well as the income tax provision adjustment for such charges. 17

Adjusted EBITDA Non-GAAP Reconciliation (1) 3Q26 3Q25 FY26 YTD FY25 YTD Net income (loss) $3,575 ($67,317) $8,786 ($64,037) Excluding: Interest income and expense, net (344) (170) (899) (483) Income tax expense (benefit) 1,231 (6,727) 2,876 (6,229) Depreciation and amortization 1,368 2,318 4,261 6,857 Stock-based compensation 1,557 1,279 4,525 4,425 Loss on currency exchange 43 (35) 85 (22) Impairments — 77,221 — 77,221 (Gain) loss from disposal of fixed assets (6) 23 (6) 23 Change in value of contingent consideration — — — (640) Reorganization expense 4 845 4 1,260 Mergers & Acquisitions expense 462 — 527 133 Adjusted EBITDA $7,890 $7,437 $20,159 $18,508 (in thousands) (1) Numbers may not add due to rounding 18

Adjusted Diluted EPS Non-GAAP Reconciliation (1) 3Q26 3Q25 FY26 YTD FY25 YTD Net income (loss) $3,575 ($67,317) $8,786 ($64,037) Excluding: Amortization 1,340 2,165 4,059 6,425 Stock-based compensation 1,557 1,279 4,525 4,425 Loss on currency exchange 43 (35) 85 (22) Mergers & Acquisitions expense 462 — 527 133 Change in value of contingent consideration — — — (640) Reorganization expense 4 845 4 1,260 Impairments — 77,221 — 77,221 (Gain) loss from disposal of fixed assets (6) 23 (6) 23 Tax effect on above adjustments (877) (5,153) (2,267) (6,119) Adjusted Net income $6,098 $9,028 $15,713 $18,669 Diluted EPS $0.18 ($3.35) $0.43 ($3.19) Adjusted Diluted EPS $0.30 $0.45 $0.78 $0.93 (in thousands, except Diluted EPS and Adjusted Diluted EPS) (1) Numbers may not add due to rounding 19

Lisa Fortuna Financial Profiles slp@finprofiles.com | +1-310-622-8251 Investor Relations Contact: Thank You

GRAPHIC

Filename: slp-20260709_g1.gif · Sequence: 7

Binary file (12171 bytes)

Download slp-20260709_g1.gif

GRAPHIC

Filename: slp_toplogo.gif · Sequence: 8

Binary file (12171 bytes)

Download slp_toplogo.gif

GRAPHIC

Filename: slpearningscalldeck263001.jpg · Sequence: 9

Binary file (51679 bytes)

Download slpearningscalldeck263001.jpg

GRAPHIC

Filename: slpearningscalldeck263002.jpg · Sequence: 10

Binary file (252601 bytes)

Download slpearningscalldeck263002.jpg

GRAPHIC

Filename: slpearningscalldeck263003.jpg · Sequence: 11

Binary file (92573 bytes)

Download slpearningscalldeck263003.jpg

GRAPHIC

Filename: slpearningscalldeck263004.jpg · Sequence: 12

Binary file (95094 bytes)

Download slpearningscalldeck263004.jpg

GRAPHIC

Filename: slpearningscalldeck263005.jpg · Sequence: 13

Binary file (83783 bytes)

Download slpearningscalldeck263005.jpg

GRAPHIC

Filename: slpearningscalldeck263006.jpg · Sequence: 14

Binary file (73647 bytes)

Download slpearningscalldeck263006.jpg

GRAPHIC

Filename: slpearningscalldeck263007.jpg · Sequence: 15

Binary file (68039 bytes)

Download slpearningscalldeck263007.jpg

GRAPHIC

Filename: slpearningscalldeck263008.jpg · Sequence: 16

Binary file (68114 bytes)

Download slpearningscalldeck263008.jpg

GRAPHIC

Filename: slpearningscalldeck263009.jpg · Sequence: 17

Binary file (73831 bytes)

Download slpearningscalldeck263009.jpg

GRAPHIC

Filename: slpearningscalldeck263010.jpg · Sequence: 18

Binary file (80679 bytes)

Download slpearningscalldeck263010.jpg

GRAPHIC

Filename: slpearningscalldeck263011.jpg · Sequence: 19

Binary file (61259 bytes)

Download slpearningscalldeck263011.jpg

GRAPHIC

Filename: slpearningscalldeck263012.jpg · Sequence: 20

Binary file (73759 bytes)

Download slpearningscalldeck263012.jpg

GRAPHIC

Filename: slpearningscalldeck263013.jpg · Sequence: 21

Binary file (56748 bytes)

Download slpearningscalldeck263013.jpg

GRAPHIC

Filename: slpearningscalldeck263014.jpg · Sequence: 22

Binary file (68474 bytes)

Download slpearningscalldeck263014.jpg

GRAPHIC

Filename: slpearningscalldeck263015.jpg · Sequence: 23

Binary file (139189 bytes)

Download slpearningscalldeck263015.jpg

GRAPHIC

Filename: slpearningscalldeck263016.jpg · Sequence: 24

Binary file (139544 bytes)

Download slpearningscalldeck263016.jpg

GRAPHIC

Filename: slpearningscalldeck263017.jpg · Sequence: 25

Binary file (90475 bytes)

Download slpearningscalldeck263017.jpg

GRAPHIC

Filename: slpearningscalldeck263018.jpg · Sequence: 26

Binary file (116120 bytes)

Download slpearningscalldeck263018.jpg

GRAPHIC

Filename: slpearningscalldeck263019.jpg · Sequence: 27

Binary file (121074 bytes)

Download slpearningscalldeck263019.jpg

GRAPHIC

Filename: slpearningscalldeck263020.jpg · Sequence: 28

Binary file (131473 bytes)

Download slpearningscalldeck263020.jpg

GRAPHIC

Filename: slpearningscalldeck263021.jpg · Sequence: 29

Binary file (62938 bytes)

Download slpearningscalldeck263021.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 31

v3.26.1

Cover

Jul. 09, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Jul. 09, 2026

Entity Registrant Name

Simulations Plus, Inc.

Entity Central Index Key

0001023459

Entity Incorporation, State or Country Code

Entity File Number

001-32046

Entity Tax Identification Number

95-4595609

Entity Address, Address Line One

600 Park Offices Drive,

Entity Address, City or Town

Durham

Entity Address, State or Province

Entity Address, Postal Zip Code

27713

City Area Code

661

Local Phone Number

723-7723

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, par value $0.001 per share

Trading Symbol

SLP

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

Entity Address, Address Line Two

Suite 300

Entity Address, Address Line Three

#4134

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 3 such as an Office Park

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine3

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration